Treatment Directed to Signalling Molecules in Patients with Advanced Differentiated Thyroid Cancer

E-ISSN： 1875-5992|13|3|483-495

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.13, Iss.3, 2013-01, pp. : 483-495

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Locally advanced differentiated thyroid cancer

By Kebebew E. Clark O.H.

Surgical Oncology, Vol. 12, Iss. 2, 2003-08 ,pp. : 91-99

Elsevier

Access to resources Recommend Favorite

Radioiodine remnant ablation in low‐risk differentiated thyroid cancer patients who had R0 dissection is an over treatment

Cancer Medicine, Vol. 4, Iss. 7, 2015-07 ,pp. : 1031-1038

John Wiley & Sons Inc

Access to resources Recommend Favorite

Predictive factors of cytotoxic damage in radioactive iodine treatment of differentiated thyroid cancer patients

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 692-698

Science Publishers

Access to resources Recommend Favorite

Assessment of radioiodine therapy efficacy for treatment of differentiated thyroid cancer patients with pulmonary metastasis undetected by chest computed tomography

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 965-968

Spandidos Publications

Access to resources Recommend Favorite

Effects of recombinant human thyroid stimulating hormone on 131I therapy for the treatment of differentiated thyroid cancer

By Guo Yiling Zhang Yingnan Chen Zuowei Xin Zhenfu

Experimental and Therapeutic Medicine, Vol. 9, Iss. 5, 2015-05 ,pp. : 1847-1850

Spandidos Publications

Access to resources Recommend Favorite